The notable activity of the drug in patients with poor prognostic
features prompted a phase 3 trial.
Results of the univariate and multivariate analysis of the most important prognostic
factors in the total group of 2062 patients with locoregional breast cancer and those treated by surgery are shown in Table 3.
Such testing provides large data sets for developing damage models and prognostic
Weight loss of more than 5-10% during the previous 3 months is a negative prognostic
In this study, we primarily analyzed clinical data from Ruijin Hospital for Chinese patients with mRCC treated with first-line targeted therapy (sorafenib or sunitinib) to identify relevant prognostic
factors for OS, using MSKCC risk groups.
and Health Management Society is a repository of prognostics
and health management knowledge and promotes interdisciplinary and internal collaboration to advance it.
Browse the full circulating tumor cells (CTCs) prognostic
technologies market report: http://www.
technology will leverage the Industrial Internet (a robust network of computers, machines and sensors that combines connectivity with advanced software analytics) to increase the airline's overall operational efficiency, an Etihad statement said.
Our work shows that when using prognostic
associations to identify biological signatures that drive cancer progression, it is important to not rely solely on a gene set's association with patient survival," said Beck.
Here we present a brief summary of traditional breast cancer prognostic
factors and prognostic
multigene classifiers used in current clinical decision making and their potential impact on future clinical management.
The publication of this article in 1975 provided an extremely practical, clinically usable, and reliable method of assigning CLL patients at the time of initial diagnosis into 3 broad prognostic
groups: Those with evidence of significant compromise to bone marrow function had the worst prognosis, those who barely fulfilled the minimum diagnostic requirement and had no other stigmata of disease had the best prognosis, and the rest of the patients belonged to an intermediate-prognosis group.
and diagnostic capabilities of a biomarker are 'two sides of the same coin' in medicine.